WallStSmart

PACCAR Inc (PCAR)vsSBC Medical Group Holdings Incorporated (SBC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PACCAR Inc generates 16305% more annual revenue ($27.78B vs $169.34M). SBC leads profitability with a 24.1% profit margin vs 8.9%. SBC trades at a lower P/E of 7.5x. PCAR earns a higher WallStSmart Score of 56/100 (C).

PCAR

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.0Value: 4.7Quality: 6.5
Piotroski: 1/9Altman Z: 2.09

SBC

Buy

52

out of 100

Grade: C-

Growth: 2.0Profit: 8.5Value: 6.7Quality: 8.5
Piotroski: 2/9Altman Z: 3.94
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PCARSignificantly Overvalued (-37.6%)

Margin of Safety

-37.6%

Fair Value

$84.77

Current Price

$118.06

$33.30 premium

UndervaluedFair: $84.77Overvalued

Intrinsic value data unavailable for SBC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PCAR1 strengths · Avg: 9.0/10
Market CapQuality
$59.41B9/10

Large-cap with strong market position

SBC6 strengths · Avg: 9.8/10
P/E RatioValuation
7.5x10/10

Attractively priced relative to earnings

Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
41.1%10/10

Strong operational efficiency at 41.1%

Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.9410/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
24.1%9/10

Keeps 24 of every $100 in revenue as profit

Areas to Watch

PCAR2 concerns · Avg: 2.5/10
Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Revenue GrowthGrowth
-8.9%2/10

Revenue declined 8.9%

SBC4 concerns · Avg: 2.5/10
Market CapQuality
$310.60M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-9.0%2/10

Revenue declined 9.0%

EPS GrowthGrowth
-47.1%2/10

Earnings declined 47.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : PCAR

The strongest argument for PCAR centers on Market Cap. PEG of 1.12 suggests the stock is reasonably priced for its growth.

Bull Case : SBC

The strongest argument for SBC centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 24.1% and operating margin at 41.1%.

Bear Case : PCAR

The primary concerns for PCAR are Piotroski F-Score, Revenue Growth.

Bear Case : SBC

The primary concerns for SBC are Market Cap, Piotroski F-Score, Revenue Growth.

Key Dynamics to Monitor

PCAR profiles as a value stock while SBC is a declining play — different risk/reward profiles.

PCAR carries more volatility with a beta of 1.03 — expect wider price swings.

PCAR is growing revenue faster at -8.9% — sustainability is the question.

PCAR generates stronger free cash flow (825M), providing more financial flexibility.

Bottom Line

PCAR scores higher overall (56/100 vs 52/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

PACCAR Inc

INDUSTRIALS · FARM & HEAVY CONSTRUCTION MACHINERY · USA

PACCAR Inc is an American Fortune 500 company and counts among the largest manufacturers of medium- and heavy-duty trucks in the world. PACCAR is engaged in the design, manufacture and customer support of light-, medium- and heavy-duty trucks under the Kenworth, Peterbilt, Leyland Trucks, and DAF nameplates. PACCAR also designs and manufactures powertrains, provides financial services and information technology, and distributes truck parts related to its principal business.

SBC Medical Group Holdings Incorporated

INDUSTRIALS · CONSULTING SERVICES · USA

SBC Medical Group Holdings, incorporated in Delaware in 2023 and headquartered in Tokyo, Japan, provides management services to cosmetic treatment centers primarily in Japan, with additional locations in Vietnam and California.

Visit Website →

Want to dig deeper into these stocks?